0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bone Morphogenetic Protein (BMP) 2 Market Research Report 2026
Published Date: 2026-01-28
|
Report Code: QYRE-Auto-10M1838
Home | Market Reports
Global Bone Morphogenetic Protein BMP 2 Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Bone Morphogenetic Protein (BMP) 2 Market Research Report 2026

Code: QYRE-Auto-10M1838
Report
2026-01-28
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bone Morphogenetic Protein (BMP) 2 Market Size

The global Bone Morphogenetic Protein (BMP) 2 market was valued at US$ 756 million in 2025 and is anticipated to reach US$ 1201 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

Bone Morphogenetic Protein (BMP) 2 Market

Bone Morphogenetic Protein (BMP) 2 Market

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Bone Morphogenetic Protein 2 (BMP-2) is a member of the bone morphogenetic protein family, a group of proteins that play a crucial role in bone and cartilage formation during embryonic development and adult tissue repair. BMP-2 is known for its potent osteoinductive properties, meaning it has the ability to stimulate the differentiation of mesenchymal stem cells into osteoblasts, the cells responsible for bone formation. This property makes BMP-2 a valuable therapeutic agent in orthopedic and dental surgeries, particularly in procedures aimed at promoting bone regeneration and spinal fusion.
Bone Morphogenetic Protein-2 (BMP-2) products are osteogenic biologics designed to stimulate new bone formation by activating cellular pathways that drive mesenchymal stem cells and osteoprogenitor cells toward an osteoblast (bone-forming) phenotype. In commercial use, BMP-2 is typically supplied as a recombinant human protein (rhBMP-2) and delivered locally at the surgical site on an absorbable carrier/scaffold (most commonly a collagen sponge or other matrix) that retains the protein long enough for it to exert its effect. Clinically, BMP-2 products are used to support bone regeneration and fusion in select orthopedic and spine procedures, especially where the surgeon wants to avoid harvesting autograft bone or where healing potential may be limited. Product design therefore centers on dose control, carrier performance, handling characteristics, and local containment, because efficacy and complication risk are strongly influenced by how and where the protein is delivered.
Key market drivers for BMP-2 products include the rising volume of spine and orthopedic procedures, growing prevalence of degenerative conditions, and the continued shift toward biologics that can reduce donor-site morbidity and shorten time to fusion in appropriately selected cases. Demand is also supported by healthcare systems seeking predictable outcomes and lower downstream costs from nonunion or delayed union, particularly in higher-risk patient groups. However, adoption is shaped by counter-pressures: safety and complication considerations, the need for careful patient selection and technique, cost sensitivity, and payer scrutiny around appropriate indications. As a result, the commercial landscape rewards suppliers that can demonstrate clear clinical value, reproducible handling in the operating room, and well-defined use protocols.
Current trends in the BMP-2 market are moving toward next-generation delivery systems that improve localization and reduce off-target effects, including modified scaffolds, composite graft matrices, and designs that better regulate release kinetics. There is also a broader trend of BMP-2 being positioned within combination strategies—for example pairing with advanced bone graft substitutes, surface-engineered implants, or minimally invasive techniques—aimed at improving fusion rates while using lower or more targeted dosing. In parallel, competitive pressure from cell-based therapies, synthetic osteoinductive substitutes, and “smart” biomaterials is pushing innovation toward safer profiles, easier workflow integration, and stronger real-world evidence. Overall, the direction of travel is “more controlled biology”: tighter control of where the signal goes, how long it persists, and which patients receive it.
This report delivers a comprehensive overview of the global Bone Morphogenetic Protein (BMP) 2 market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bone Morphogenetic Protein (BMP) 2. The Bone Morphogenetic Protein (BMP) 2 market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Bone Morphogenetic Protein (BMP) 2 market comprehensively. Regional market sizes by Type, by Application, by Feature, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Bone Morphogenetic Protein (BMP) 2 manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Bone Morphogenetic Protein (BMP) 2 Market Report

Report Metric Details
Report Name Bone Morphogenetic Protein (BMP) 2 Market
Accounted market size in 2025 US$ 756 million
Forecasted market size in 2032 US$ 1201 million
CAGR 6.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Sponge
  • Gel
Segment by Feature
  • Gene Recombination Technology
  • Isolation and Purification
Segment by Application
  • Spinal Fusion
  • Trauma Surgery
  • Oral Maxillofacial Surgery
  • reconstructive surgery
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Jiuyuan Gene Engineering, Cellumed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Feature, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Bone Morphogenetic Protein (BMP) 2 companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Bone Morphogenetic Protein (BMP) 2 Market growing?

Ans: The Bone Morphogenetic Protein (BMP) 2 Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the Bone Morphogenetic Protein (BMP) 2 Market size in 2032?

Ans: The Bone Morphogenetic Protein (BMP) 2 Market size in 2032 will be US$ 1201 million.

Who are the main players in the Bone Morphogenetic Protein (BMP) 2 Market report?

Ans: The main players in the Bone Morphogenetic Protein (BMP) 2 Market are Medtronic, Jiuyuan Gene Engineering, Cellumed

What are the Application segmentation covered in the Bone Morphogenetic Protein (BMP) 2 Market report?

Ans: The Applications covered in the Bone Morphogenetic Protein (BMP) 2 Market report are Spinal Fusion, Trauma Surgery, Oral Maxillofacial Surgery, reconstructive surgery

What are the Type segmentation covered in the Bone Morphogenetic Protein (BMP) 2 Market report?

Ans: The Types covered in the Bone Morphogenetic Protein (BMP) 2 Market report are Sponge, Gel

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Sponge
1.2.3 Gel
1.3 Market by Feature
1.3.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Feature: 2021 vs 2025 vs 2032
1.3.2 Gene Recombination Technology
1.3.3 Isolation and Purification
1.4 Market by Application
1.4.1 Global Bone Morphogenetic Protein (BMP) 2 Market Growth by Application: 2021 vs 2025 vs 2032
1.4.2 Spinal Fusion
1.4.3 Trauma Surgery
1.4.4 Oral Maxillofacial Surgery
1.4.5 reconstructive surgery
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Perspective (2021–2032)
2.2 Global Bone Morphogenetic Protein (BMP) 2 Growth Trends by Region
2.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Region (2021–2026)
2.2.3 Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Region (2027–2032)
2.3 Bone Morphogenetic Protein (BMP) 2 Market Dynamics
2.3.1 Bone Morphogenetic Protein (BMP) 2 Industry Trends
2.3.2 Bone Morphogenetic Protein (BMP) 2 Market Drivers
2.3.3 Bone Morphogenetic Protein (BMP) 2 Market Challenges
2.3.4 Bone Morphogenetic Protein (BMP) 2 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bone Morphogenetic Protein (BMP) 2 Players by Revenue
3.1.1 Global Top Bone Morphogenetic Protein (BMP) 2 Players by Revenue (2021–2026)
3.1.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Players (2021–2026)
3.2 Global Top Bone Morphogenetic Protein (BMP) 2 Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Bone Morphogenetic Protein (BMP) 2 Revenue
3.4 Global Bone Morphogenetic Protein (BMP) 2 Market Concentration Ratio
3.4.1 Global Bone Morphogenetic Protein (BMP) 2 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bone Morphogenetic Protein (BMP) 2 Revenue in 2025
3.5 Global Key Players of Bone Morphogenetic Protein (BMP) 2 Head Offices and Areas Served
3.6 Global Key Players of Bone Morphogenetic Protein (BMP) 2, Products and Applications
3.7 Global Key Players of Bone Morphogenetic Protein (BMP) 2, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Bone Morphogenetic Protein (BMP) 2 Breakdown Data by Type
4.1 Global Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Type (2021–2026)
4.2 Global Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Type (2027–2032)
5 Bone Morphogenetic Protein (BMP) 2 Breakdown Data by Application
5.1 Global Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Application (2021–2026)
5.2 Global Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Bone Morphogenetic Protein (BMP) 2 Market Size (2021–2032)
6.2 North America Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2021–2026)
6.4 North America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bone Morphogenetic Protein (BMP) 2 Market Size (2021–2032)
7.2 Europe Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2021–2026)
7.4 Europe Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size (2021–2032)
8.2 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2021–2026)
8.4 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Bone Morphogenetic Protein (BMP) 2 Market Size (2021–2032)
9.2 Latin America Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2021–2026)
9.4 Latin America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size (2021–2032)
10.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2021–2026)
10.4 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Introduction
11.1.4 Medtronic Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2021–2026)
11.1.5 Medtronic Recent Development
11.2 Jiuyuan Gene Engineering
11.2.1 Jiuyuan Gene Engineering Company Details
11.2.2 Jiuyuan Gene Engineering Business Overview
11.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Introduction
11.2.4 Jiuyuan Gene Engineering Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2021–2026)
11.2.5 Jiuyuan Gene Engineering Recent Development
11.3 Cellumed
11.3.1 Cellumed Company Details
11.3.2 Cellumed Business Overview
11.3.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Introduction
11.3.4 Cellumed Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2021–2026)
11.3.5 Cellumed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Sponge
 Table 3. Key Players of Gel
 Table 4. Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Feature (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Key Players of Gene Recombination Technology
 Table 6. Key Players of Isolation and Purification
 Table 7. Key Players of Direct Selling
 Table 8. Key Players of Distribution
 Table 9. Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 10. Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 11. Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region (US$ Million), 2021–2026
 Table 12. Global Bone Morphogenetic Protein (BMP) 2 Market Share by Region (2021–2026)
 Table 13. Global Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 14. Global Bone Morphogenetic Protein (BMP) 2 Market Share by Region (2027–2032)
 Table 15. Bone Morphogenetic Protein (BMP) 2 Market Trends
 Table 16. Bone Morphogenetic Protein (BMP) 2 Market Drivers
 Table 17. Bone Morphogenetic Protein (BMP) 2 Market Challenges
 Table 18. Bone Morphogenetic Protein (BMP) 2 Market Restraints
 Table 19. Global Bone Morphogenetic Protein (BMP) 2 Revenue by Players (US$ Million), 2021–2026
 Table 20. Global Bone Morphogenetic Protein (BMP) 2 Market Share by Players (2021–2026)
 Table 21. Global Top Bone Morphogenetic Protein (BMP) 2 Players by Tier (Tier 1, Tier 2, and Tier 3), based on Bone Morphogenetic Protein (BMP) 2 Revenue, 2025
 Table 22. Ranking of Global Top Bone Morphogenetic Protein (BMP) 2 Companies by Revenue (US$ Million) in 2025
 Table 23. Global 5 Largest Players Market Share by Bone Morphogenetic Protein (BMP) 2 Revenue (CR5 and HHI), 2021–2026
 Table 24. Global Key Players of Bone Morphogenetic Protein (BMP) 2, Headquarters and Area Served
 Table 25. Global Key Players of Bone Morphogenetic Protein (BMP) 2, Products and Applications
 Table 26. Global Key Players of Bone Morphogenetic Protein (BMP) 2, Date of General Availability (GA)
 Table 27. Mergers and Acquisitions, Expansion Plans
 Table 28. Global Bone Morphogenetic Protein (BMP) 2 Market Size by Type (US$ Million), 2021–2026
 Table 29. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Type (2021–2026)
 Table 30. Global Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 31. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Type (2027–2032)
 Table 32. Global Bone Morphogenetic Protein (BMP) 2 Market Size by Application (US$ Million), 2021–2026
 Table 33. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Application (2021–2026)
 Table 34. Global Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 35. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Application (2027–2032)
 Table 36. North America Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. North America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (US$ Million), 2021–2026
 Table 38. North America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (US$ Million), 2027–2032
 Table 39. Europe Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Europe Bone Morphogenetic Protein (BMP) 2 Market Size by Country (US$ Million), 2021–2026
 Table 41. Europe Bone Morphogenetic Protein (BMP) 2 Market Size by Country (US$ Million), 2027–2032
 Table 42. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size by Region (US$ Million), 2021–2026
 Table 44. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size by Region (US$ Million), 2027–2032
 Table 45. Latin America Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Latin America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (US$ Million), 2021–2026
 Table 47. Latin America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (US$ Million), 2027–2032
 Table 48. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 49. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size by Country (US$ Million), 2021–2026
 Table 50. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size by Country (US$ Million), 2027–2032
 Table 51. Medtronic Company Details
 Table 52. Medtronic Business Overview
 Table 53. Medtronic Bone Morphogenetic Protein (BMP) 2 Product
 Table 54. Medtronic Revenue in Bone Morphogenetic Protein (BMP) 2 Business (US$ Million), 2021–2026
 Table 55. Medtronic Recent Development
 Table 56. Jiuyuan Gene Engineering Company Details
 Table 57. Jiuyuan Gene Engineering Business Overview
 Table 58. Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Product
 Table 59. Jiuyuan Gene Engineering Revenue in Bone Morphogenetic Protein (BMP) 2 Business (US$ Million), 2021–2026
 Table 60. Jiuyuan Gene Engineering Recent Development
 Table 61. Cellumed Company Details
 Table 62. Cellumed Business Overview
 Table 63. Cellumed Bone Morphogenetic Protein (BMP) 2 Product
 Table 64. Cellumed Revenue in Bone Morphogenetic Protein (BMP) 2 Business (US$ Million), 2021–2026
 Table 65. Cellumed Recent Development
 Table 66. Research Programs/Design for This Report
 Table 67. Key Data Information from Secondary Sources
 Table 68. Key Data Information from Primary Sources
 Table 69. Authors List of This Report


List of Figures
 Figure 1. Bone Morphogenetic Protein (BMP) 2 Picture
 Figure 2. Global Bone Morphogenetic Protein (BMP) 2 Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Bone Morphogenetic Protein (BMP) 2 Market Share by Type: 2025 vs 2032
 Figure 4. Sponge Features
 Figure 5. Gel Features
 Figure 6. Global Bone Morphogenetic Protein (BMP) 2 Market Size Comparison by Feature (US$ Million), 2021–2032
 Figure 7. Gene Recombination Technology Features
 Figure 8. Isolation and Purification Features
 Figure 9. Direct Selling Features
 Figure 10. Distribution Features
 Figure 11. Global Bone Morphogenetic Protein (BMP) 2 Market Size by Application (US$ Million), 2021–2032
 Figure 12. Global Bone Morphogenetic Protein (BMP) 2 Market Share by Application: 2025 vs 2032
 Figure 13. Spinal Fusion Case Studies
 Figure 14. Trauma Surgery Case Studies
 Figure 15. Oral Maxillofacial Surgery Case Studies
 Figure 16. reconstructive surgery Case Studies
 Figure 17. Bone Morphogenetic Protein (BMP) 2 Report Years Considered
 Figure 18. Global Bone Morphogenetic Protein (BMP) 2 Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 19. Global Bone Morphogenetic Protein (BMP) 2 Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 20. Global Bone Morphogenetic Protein (BMP) 2 Market Share by Region: 2025 vs 2032
 Figure 21. Global Bone Morphogenetic Protein (BMP) 2 Market Share by Players in 2025
 Figure 22. Global Bone Morphogenetic Protein (BMP) 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 23. The Top 10 and 5 Players Market Share by Bone Morphogenetic Protein (BMP) 2 Revenue in 2025
 Figure 24. North America Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. North America Bone Morphogenetic Protein (BMP) 2 Market Share by Country (2021–2032)
 Figure 26. United States Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Canada Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Europe Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Europe Bone Morphogenetic Protein (BMP) 2 Market Share by Country (2021–2032)
 Figure 30. Germany Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. France Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. U.K. Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Italy Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Russia Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Ireland Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Share by Region (2021–2032)
 Figure 38. China Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Japan Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. South Korea Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Southeast Asia Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. India Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Australia & New Zealand Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Latin America Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Latin America Bone Morphogenetic Protein (BMP) 2 Market Share by Country (2021–2032)
 Figure 46. Mexico Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Brazil Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Share by Country (2021–2032)
 Figure 50. Israel Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. UAE Bone Morphogenetic Protein (BMP) 2 Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. Medtronic Revenue Growth Rate in Bone Morphogenetic Protein (BMP) 2 Business (2021–2026)
 Figure 54. Jiuyuan Gene Engineering Revenue Growth Rate in Bone Morphogenetic Protein (BMP) 2 Business (2021–2026)
 Figure 55. Cellumed Revenue Growth Rate in Bone Morphogenetic Protein (BMP) 2 Business (2021–2026)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc